deltatrials

Allergan Clinical Trials

Sponsors / Allergan

Allergan is listed as the lead sponsor on 707 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 1 are in recruitment, 3 are active non-recruiting, and 594 have reached completion. 73 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Across the portfolio, planned enrollment totals 255,772 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

707
Total Trials
1
Recruiting
3
Other Active
594
Completed
73
Terminated / Withdrawn
255,772
Total Enrollment

Termination reasons: Other38% · Recruitment26% · Business23% · Safety4% · Funding4% · PI/or_Site1% · Regulatory1% · Efficacy1%

Recent Terminations

  • NCT03580044 Phase PHASE3 Stopped Jan 2023
    Serious Bacterial Infection
    "Recruitment of patients with serious infections caused by gram-negative bacteria producing MBL has been challenging. Date study terminated: 16-Dec-2022."
  • NCT04126031 Phase PHASE2 Stopped Dec 2022
    Gram-negative Bacterial Infection
    "Following regulatory consultation, the Sponsor has decided to terminate the study and analyze the current dataset. The decision to terminate was solely based on a business decision, not due to safety concerns."
  • NCT04500418 Phase PHASE2 Stopped Jul 2021
    Covid19
    "Despite multiple efforts, no further patient could be enrolled since 03/05/2021. A continuation of the study is therefore no longer justified"
  • NCT03420781 Phase PHASE3 Stopped Oct 2020
    Diabetes Mellitus
    "The Relamorelin program is being terminated solely based on a business decision."
  • NCT03786380 Phase PHASE3 Stopped Oct 2020
    Gastroparesis
    "The Relamorelin program is being terminated solely based on a business decision."
  • NCT03426345 Phase PHASE3 Stopped Jul 2020
    Diabetes Mellitus
    "The Relamorelin program is being terminated solely based on a business decision"
  • NCT03827564 Phase NA Stopped Jun 2020
    Dry Eye Syndromes
    "Study discontinued due to business reasons."
  • NCT03691415 Stopped Apr 2020
    Submental Fullness
    "Study discontinued due to business decisions."
  • NCT03469258 Phase PHASE2 Stopped Oct 2019
    Pancreatic Cancer
    "Sponsorship for trial was halted after company acquisition"
  • NCT03429556 Phase PHASE2 Stopped Jul 2018
    Abdominoplasty
    "Sponsor decision to terminate early"

Active Trials (3 total)

Top Conditions

Glaucoma (39) Dry eye syndromes (33) Glaucoma, open-angle (32) Macular edema (23) Ocular hypertension (22) Diabetic macular edema (21) Acne vulgaris (17) Overactive bladder (16) Dry eye (13) Migraine disorders (11)

Top Locations

Houston, United States (58) New York, United States (56) San Diego, United States (53) Newport Beach, United States (49) San Antonio, United States (49) Dallas, United States (46) Austin, United States (44) St. Louis, United States (43) London, United Kingdom (42) Los Angeles, United States (42)